event,time
Here is the table of events and timestamps:,
31 years old ,0.0
female ,0.0
non-smoking ,0.0
Caucasian ,0.0
no past medical history ,0.0
sudden-onset severe headache ,-5.0
left arm numbness ,-5.0
cranial computed tomography (CT) scan ,-5.0
grade 2 (Hunt and Hess scale) SAH ,-5.0
admitted to the neurosurgical ward ,-5.0
digital subtraction angiography (DSA) ,-5.0
ruptured right middle cerebral artery aneurysm ,-5.0
percutaneous endovascular coil embolization ,-5.0
fever ,-61.0
chills ,-61.0
constant abdominal pain ,-61.0
purulent uterine discharge ,-61.0
denies urinary or respiratory symptoms ,-61.0
sepsis ,-57.0
septic shock ,-57.0
transferred to the intensive care unit ,-57.0
body temperature 38.3°C ,-57.0
invasive blood pressure 90/65 mmHg ,-57.0
heart rate 135/min ,-57.0
arterial oxygen saturation 82% ,-57.0
mild disorientation ,-57.0
slower capillary refill ,-57.0
coarse rales ,-57.0
sequential organ failure assessment (SOFA) score 4 ,-57.0
hemoglobin 6.8 g/dL ,-57.0
d-dimers 4.58 μg/mL ,-57.0
C-reactive protein 322 mg/L ,-57.0
fibrinogen concentration 6.4 mL ,-57.0
blood culture E. coli ,-57.0
chest radiography pulmonary nodules ,-57.0
CT of the thorax pulmonary nodules ,-57.0
transvaginal ultrasound enlarged uterus ,-57.0
abdominal magnetic resonance imaging (MRI) enlarged heterogenous myometrial mass ,-57.0
splenic metastatic lesion ,-57.0
"serum β-human chorionic gonadotrophin (β-hCG) 232,085 mUI/mL ",-57.0
suction evacuation and curettage ,-57.0
choriocarcinoma diagnosis ,-57.0
International Federation of Gynecology and Obstetrics (FIGO) modified WHO prognostic scoring system for gestational trophoblastic disease (GTN) ,-57.0
total score 12 ,-57.0
diagnosed with metastatic choriocarcinoma at high risk ,-57.0
low-dose etoposide (100 mg/m2) in combination with cisplatin (20 mg/m2) ,-57.0
EMA/CO regimen ,-50.0
"etoposide, methotrexate, and actinomycin D, alternating on a weekly basis with cyclophosphamide and vincristine ",-50.0
completed six cycles ,-50.0
β-hCG levels plateaued above normal ,-50.0
MRI of the brain and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT scan ,-50.0
decreased pulmonary nodules and a uterine mass ,-50.0
revised FIGO score 7 ,-50.0
therapeutic regimen changed to EP/EMA ,-43.0
"etoposide plus cisplatin on day 1, followed by etoposide, methotrexate, and actinomycin D on day 8 ",-43.0
β-hCG normalization ,-43.0
grade 3 neutropenia ,-43.0
grade 2 fatigue ,-43.0
grade 2 nausea ,-43.0
grade 2 hair loss ,-43.0
discharged ,24.0
